STERIS SVP Fraser granted 10,492 stock options

STERIS plc SVP & Chief HRO Mary Clare Fraser reported equity awards on June 2, 2026.

Rhea-AI Filing Summary

STERIS plc SVP & Chief HRO Mary Clare Fraser reported equity awards on June 2, 2026. She received a grant of 10,492 employee stock options with an exercise price of 230.74 per share, vesting in four annual tranches from 2027 to 2030 and expiring in 2036. She also acquired 3,009 ordinary shares, while 591 shares were withheld at 209.76 per share to cover tax obligations on 2,028 restricted shares that vested. After these transactions she directly holds 14,627 ordinary shares, of which 7,554 remain restricted with scheduled lapses between 2026 and 2029.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Fraser Mary Clare

Role SVP & Chief HRO

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy)	10,492	$0.00	$0.00
Grant/Award	Ordinary Shares	3,009	$0.00	$0.00
Exercise Price or Tax Liability	Ordinary Shares	591	$209.76	$124K

Holdings After Transaction: Employee Stock Option (right to buy) — 10,492 contracts (Direct); Ordinary Shares — 14,627 shares (Direct)

Footnotes (3)

1. F1. As of June 2, 2026, 7,554 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 835 on June 3, 2026; 1,360 on June 4, 2026; 1,003 on June 2, 2027; 835 on June 3, 2027; 680 on June 4, 2027; 1,003 on June 2, 2028; 835 on June 5, 2028 and 1,003 on June 4, 2029.
2. F2. 591 shares were withheld from the 2,028 restricted shares that vested on June 2, 2026. These 591 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 2, 2026.
3. F3. This option becomes exercisable as follows: 2,623 on June 2, 2027, 2,623 on June 2, 2028, 2,623 on June 4, 2029 and 2,623 on June 3, 2030.

Key Figures

Options granted: 10492.0000 Option exercise price: 230.7400 Ordinary shares acquired: 3009.0000 +5 more

8 metrics

Options granted 10492.0000 Employee stock options granted to Mary Clare Fraser on June 2, 2026

Option exercise price 230.7400 Per-share exercise price for the 10,492 employee stock options

Ordinary shares acquired 3009.0000 Ordinary shares granted to Mary Clare Fraser on June 2, 2026

Shares withheld for taxes 591.0000 Shares withheld from 2,028 vested restricted shares to satisfy tax obligations

Tax withholding valuation price 209.7600 Per-share valuation of withheld shares based on NYSE closing price on June 2, 2026

Post-transaction ordinary shares 14,627 Direct ordinary share holdings of Mary Clare Fraser after these transactions

Restricted ordinary shares 7554 Number of Fraser’s ordinary shares that remain restricted as of June 2, 2026

Vested restricted shares 2028 Restricted shares that vested on June 2, 2026, from which 591 were withheld for taxes

Key Terms

Employee Stock Option (right to buy), restricted shares, NYSE closing market price, tax-withholding disposition

4 terms

Employee Stock Option (right to buy) financial

"security_title: Employee Stock Option (right to buy)"

restricted shares financial

"591 shares were withheld from the 2,028 restricted shares that vested"

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

NYSE closing market price financial

"valued at the NYSE closing market price on June 2, 2026"

tax-withholding disposition financial

"transaction_action: tax-withholding disposition"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did STERIS (STE) grant to Mary Clare Fraser on June 2, 2026?

On June 2, 2026, Mary Clare Fraser received 10,492 employee stock options with an exercise price of 230.74 per share and was granted 3,009 ordinary shares. These equity awards are part of her compensation as SVP & Chief HRO of STERIS plc.

How many STERIS (STE) ordinary shares does Mary Clare Fraser hold after the reported transactions?

After the reported transactions, Mary Clare Fraser directly holds 14,627 ordinary shares of STERIS plc. As of June 2, 2026, 7,554 of these shares are restricted, with restrictions scheduled to lapse in several tranches between 2026 and 2029.

What are the terms of Mary Clare Fraser's new STERIS (STE) stock options?

Mary Clare Fraser was granted 10,492 employee stock options exercisable at 230.74 per share. The options vest in four equal tranches of 2,623 shares in 2027, 2028, 2029 and 2030 and have an expiration date of June 2, 2036.

How many STERIS (STE) shares were withheld for taxes in this Form 4 filing?

A total of 591 ordinary shares were withheld to cover tax obligations. These shares came from 2,028 restricted shares that vested on June 2, 2026 and were valued at the NYSE closing price of 209.76 per share on that date.

How many of Mary Clare Fraser's STERIS (STE) shares remain restricted and when do restrictions lapse?

As of June 2, 2026, 7,554 ordinary shares held by Mary Clare Fraser are restricted. These restrictions lapse in scheduled amounts from 2026 through 2029, including tranches on June 3 and 4 of 2026 and 2027, and in June 2028 and June 4, 2029.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/04/2026 - 04:32 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fraser Mary Clare

(Last) (First) (Middle)

70 SIR JOHN ROGERSON'S QUAY

(Street)

DUBLIN 2 D02 R296

(City) (State) (Zip)

IRELAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
STERIS plc [ STE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP & Chief HRO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	06/02/2026		A		3,009	A	$0	15,218(1)	D
Ordinary Shares	06/02/2026		F		591(2)	D	$209.76	14,627(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$230.74	06/02/2026		A		10,492		(3)	06/02/2036	Ordinary Shares	10,492	$0	10,492	D

Explanation of Responses:

1. As of June 2, 2026, 7,554 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 835 on June 3, 2026; 1,360 on June 4, 2026; 1,003 on June 2, 2027; 835 on June 3, 2027; 680 on June 4, 2027; 1,003 on June 2, 2028; 835 on June 5, 2028 and 1,003 on June 4, 2029.

2. 591 shares were withheld from the 2,028 restricted shares that vested on June 2, 2026. These 591 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 2, 2026.

3. This option becomes exercisable as follows: 2,623 on June 2, 2027, 2,623 on June 2, 2028, 2,623 on June 4, 2029 and 2,623 on June 3, 2030.

Remarks:

	/s/ John P. Ubbing, Authorized Representative under Power of Attorney	06/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)